On March 19, 2024, Avidity Biosciences, Inc. closed the transaction. The transaction included participation from 45 investors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.7 USD | +0.38% | +0.04% | +197.46% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+197.46% | 2.54B | |
+0.82% | 91.94B | |
-3.16% | 38.74B | |
+64.83% | 26.66B | |
-12.40% | 15.32B | |
-5.86% | 13.3B | |
-11.38% | 11.65B | |
+156.85% | 10.37B | |
-49.84% | 10.12B | |
+2.32% | 9.06B |
- Stock Market
- Equities
- RNA Stock
- News Avidity Biosciences, Inc.
- Avidity Biosciences, Inc. announced that it has received $400.208766 million in funding